CME Group Q4 2024 Earnings Report

Key Takeaways

CME Group Inc. reported strong financial results for Q4 2024, with a 6% increase in revenue, adjusted net income, and adjusted earnings per share. Revenue reached $1.5 billion, operating income was $947 million, and net income stood at $875 million. Adjusted net income was $919 million, with adjusted diluted EPS of $2.52. The company also saw an increase in clearing and transaction fees revenue and a strong performance across asset classes.

Total Revenue

$1.53B

Previous year: $1.44B

+6.0%

EPS

$2.52

Previous year: $2.37

+6.3%

Total Futures & Options Contract Volume

25.5M

Previous year: 25.51M

+-0.0%

Aggregate ADV

25.5M

Previous year: 25.51M

-0.1%

Total Futures & Options Fees

$1.23B

Previous year: $1.18B

+4.0%

Cash and Equivalents

$3.1B

Previous year: $3.03B

+2.3%

CME Group Revenue

CME Group EPS

CME Group Revenue by Segment

Forward Guidance

CME Group expects continued growth in trading volumes across various asset classes, driven by macroeconomic uncertainty and global market demand.

Positive Outlook

Record trading volumes in interest rates and agricultural markets.
Strong demand for risk management products.
Increased non-U.S. trading activity.
Higher market data revenue.
Growing interest in alternative asset classes.

Challenges Ahead

Macroeconomic uncertainties and geopolitical risks.
Potential regulatory changes impacting derivatives trading.
Increased competition from alternative trading platforms.
Fluctuations in market volatility affecting trading volumes.
Ongoing operational costs associated with technology investments.